Table 1.

Impact of the SARS‐CoV‐2 Epidemic on the Routine Activity of 22 Italian LT Programs

	North‐Central Region	South‐Central Region	Overall
Number of LT centers, n	14	8	22
Center policy on LT
Regular activity	11 (79)	6 (75)	17 (77)
Reduced activity	3 (21)	2 (25)	5 (23)
Center policy on transplant recipient follow‐up
Reduced activity	14 (100)	8 (100)	22 (100)
Center policy on pretransplant evaluation
Regular activity	4 (29)	3 (38)	7 (32)
Reduced activity	9 (64)	5 (62)	14 (64)
Suspended activity	1 (7)	0 (0)	1 (5)
Center policy on nasopharyngeal swab evaluation for LT candidates
For all potential recipients	12 (86)	6 (75)	18 (82)
In the presence of clinical suspicion or respiratory symptoms	2 (14)	2 (25)	4 (18)
Center volume of activity (number of LTs) from February 1 to March 15, n
2018	128	29	157
February 1 to February 28	68	18	86
March 1 to March 15	60	11	71
2019	134	34	168
February 1 to February 28	95	22	117
March 1 to March 15	39	12	51
2020	121	35	156
February 1 to February 29	98	21	119
March 1 to March 15	23	14	37
Assessment of the COVID‐19 infection in transplant recipients
Total positive for COVID‐19, n	24	0	24
Transplanted in 2020	5 (21)	0	5 (21)
Required hospitalization	17 (71)	0	17 (71)
Required ICU admission	3 (12)	0	3 (12)
Dead	5 (21)	0	5 (21)
Assessment of the COVID‐19 infection in health care providers
Total positive to COVID‐19, n	35	2	37
Physicians	16 (46)	1 (50)	17 (46)
Other health care providers	19 (54)	1 (50)	20 (54)
LRLT
Total number of centers, n	4	3	7
Center policy on LT
Regular activity	1 (25)	2 (67)	3 (43)
Reduced activity	1 (25)	0	1 (14)
Suspended activity	2 (50)	1 (33)	3 (43)
Center volume of LRLT activity from February 1 to March 15, n
2018	0	5	5
2019	0	2	2
2020	0	3	3

Data are given as n (%) unless otherwise noted.